Glutamate-producing brain cells in a movement-control hub linked to Parkinson's symptoms
Role of Glutamatergic Neurons in External Globus Pallidus in the Behavioral Deficits in Animal Models of Progressive Dopamine Depletion
This project looks at whether a specific group of glutamate-making brain cells in the external globus pallidus cause movement and attention problems like those seen in Parkinson's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11140960 on NIH RePORTER |
What this research studies
From the patient's point of view, researchers use animal models that mimic progressive dopamine loss to study a newly identified type of glutamate-producing neuron in a key movement-control area of the brain. They map where these cells send signals, record their activity during movement and attention tasks, and change their activity to see how behavior is affected. By linking this cell type to particular Parkinson's-like symptoms in animals, the team hopes to point toward new targets for future treatments.
Who could benefit from this research
Good fit: People living with Parkinson's disease, especially those with movement and attention problems, are the patient group most relevant to this research.
Not a fit: People without Parkinson's disease or whose symptoms are due to unrelated conditions are unlikely to receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could point to new brain-cell targets that lead to therapies improving movement and cognitive symptoms in Parkinson's disease.
How similar studies have performed: Previous animal studies manipulating specific basal ganglia cell types have changed movement symptoms, but focusing on VGLUT2-expressing glutamatergic neurons in the external globus pallidus is a newer approach.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Lim, Byungkook — University of California, San Diego
- Study coordinator: Lim, Byungkook
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.